Balchem (BCPC) reports Q3 2025 results; 8-K furnishes press release

Balchem Corporation furnished an update on its business by reporting earnings for the quarter ended September 30, 2025.

Accepted by SEC EDGAR 10/21/2025 - 07:17 AM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Balchem Corporation furnished an update on its business by reporting earnings for the quarter ended September 30, 2025. The company issued a press release with the results, which is attached as Exhibit 99.1.

The disclosure was provided under Item 2.02 and is designated as “furnished,” meaning it is not deemed filed under Section 18 of the Exchange Act. Balchem’s common stock trades on Nasdaq under the symbol BCPC.

8-K Event Classification

2 items: 2.02, 9.01

2 items

Item 2.02 Results of Operations and Financial Condition Financial

Disclosure of earnings results, typically an earnings press release or preliminary financials.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Balchem (BCPC) announce in this 8-K?

Balchem reported earnings for the quarter ended September 30, 2025 and furnished a press release as Exhibit 99.1.

Which period does the update cover for BCPC?

It covers the company’s financial results for the third quarter ended September 30, 2025.

Is the information in this 8-K considered filed or furnished?

The information is furnished under Item 2.02 and is not deemed filed under Section 18 of the Exchange Act.

Where can I find the detailed results for BCPC?

The detailed results are in the press release attached as Exhibit 99.1.

What is Balchem’s trading symbol and exchange?

Balchem’s common stock trades on The Nasdaq Stock Market LLC under the symbol BCPC.

What other exhibit accompanies the filing?

The filing includes the Cover Page Interactive Data File as Exhibit 104.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

false000000932600000093262025-10-212025-10-21

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (date of earliest event reported): October 21, 2025

Balchem Corporation

(Exact name of registrant as specified in its charter)

Maryland			1-13648			13-2578432
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

5 Paragon Drive, Montvale, NJ 07645

(Address of principal executive offices) (Zip Code)

Registrant’s telephone number, including area code: (845) 326-5600

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading symbol			Name of each exchange on which registered
Common Stock, par value $.06-2/3 per share			BCPC			The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company    ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02     Results of Operations and Financial Condition

On October 21, 2025, Balchem Corporation reported earnings for the quarter ended September 30, 2025, and certain other information. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1.

The information in this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01			Financial Statements and Exhibits
(d)			Exhibits
Exhibit No.			Description
99.1			Press Release of Balchem Corporation, dated October 21, 2025, reporting its financial results for the third quarter of 2025 and certain other information
104			Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BALCHEM CORPORATION

By:/s/ Hatsuki Miyata

Hatsuki Miyata

Executive Vice President, Chief Legal Officer and Secretary

Date: October 21, 2025